Incapacitating solar urticaria: successful treatment with omalizumab

Incapacitating solar urticaria: successful treatment with omalizumab

Abstract: Solar urticaria is a rare form of physical urticaria mediated by immunoglobulin E. The lesions appear immediately after the sun exposure, interfering with the patient's normal daily life. Omalizumab, a monoclonal anti-IgE antibody, has been recently approved for the treatment of chronic spontaneous urticaria, and the latest reports support its role also in the treatment of solar urticaria. Hereby, we report a case of solar urticaria refractory to conventional treatment strategies, with an excellent response to treatment with omalizumab and phototesting normalization.

Saved in:
Bibliographic Details
Main Authors: Kieselova,Katarina, Santiago,Felicidade, Henrique,Martinha
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Dermatologia 2019
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962019000300331
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0365-05962019000300331
record_format ojs
spelling oai:scielo:S0365-059620190003003312019-07-25Incapacitating solar urticaria: successful treatment with omalizumabKieselova,KatarinaSantiago,FelicidadeHenrique,Martinha Immunoglobulin E Light Photosensitivity disorders Urticaria Abstract: Solar urticaria is a rare form of physical urticaria mediated by immunoglobulin E. The lesions appear immediately after the sun exposure, interfering with the patient's normal daily life. Omalizumab, a monoclonal anti-IgE antibody, has been recently approved for the treatment of chronic spontaneous urticaria, and the latest reports support its role also in the treatment of solar urticaria. Hereby, we report a case of solar urticaria refractory to conventional treatment strategies, with an excellent response to treatment with omalizumab and phototesting normalization.info:eu-repo/semantics/openAccessSociedade Brasileira de DermatologiaAnais Brasileiros de Dermatologia v.94 n.3 20192019-05-01info:eu-repo/semantics/reporttext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962019000300331en10.1590/abd1806-4841.20198109
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Kieselova,Katarina
Santiago,Felicidade
Henrique,Martinha
spellingShingle Kieselova,Katarina
Santiago,Felicidade
Henrique,Martinha
Incapacitating solar urticaria: successful treatment with omalizumab
author_facet Kieselova,Katarina
Santiago,Felicidade
Henrique,Martinha
author_sort Kieselova,Katarina
title Incapacitating solar urticaria: successful treatment with omalizumab
title_short Incapacitating solar urticaria: successful treatment with omalizumab
title_full Incapacitating solar urticaria: successful treatment with omalizumab
title_fullStr Incapacitating solar urticaria: successful treatment with omalizumab
title_full_unstemmed Incapacitating solar urticaria: successful treatment with omalizumab
title_sort incapacitating solar urticaria: successful treatment with omalizumab
description Abstract: Solar urticaria is a rare form of physical urticaria mediated by immunoglobulin E. The lesions appear immediately after the sun exposure, interfering with the patient's normal daily life. Omalizumab, a monoclonal anti-IgE antibody, has been recently approved for the treatment of chronic spontaneous urticaria, and the latest reports support its role also in the treatment of solar urticaria. Hereby, we report a case of solar urticaria refractory to conventional treatment strategies, with an excellent response to treatment with omalizumab and phototesting normalization.
publisher Sociedade Brasileira de Dermatologia
publishDate 2019
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962019000300331
work_keys_str_mv AT kieselovakatarina incapacitatingsolarurticariasuccessfultreatmentwithomalizumab
AT santiagofelicidade incapacitatingsolarurticariasuccessfultreatmentwithomalizumab
AT henriquemartinha incapacitatingsolarurticariasuccessfultreatmentwithomalizumab
_version_ 1756412633733398528

Similar Items